Mimabs
Preclinical antibody and ADC discovery and development services for biotech, pharmaceutical and academic research partners
Highlights
- Hiring1 open role
- New on EvolcAdded 2026-10-29
About Mimabs
MImAbs is a preclinical contract research organization providing antibody and antibody-drug conjugate discovery and development services. Its work includes antibody generation, engineering, production, conjugation, characterization and pharmacology.
It serves biotechnology companies, pharmaceutical companies and academic partners through fee-for-service projects and tailored research support. The company is based in Marseille and has been part of Janvier Group Biosciences since 2023.
MImAbs was created in 2011 and holds ISO 9001 certification. It has an open position for a protein biochemistry specialist.
Product: Fee-for-service preclinical antibody and ADC discovery, engineering, production, characterization and pharmacology services.
Jobs at Mimabs (1)
Mimabs is hiring for one role.
Spécialiste en biochimie des protéines H/F
New on Evolc
Leadership
- Nadège LABORDE · General ManagerSource: company website
More biotech & pharma companies
Mycea
Develops fungal-extract crop protection candidates for agricultural and biocontrol partnersNew on EvolcNaemos
Plant-based cosmetic active ingredients from indoor-farmed microgreens and eco-extraction, sold to cosmetic brandsYoung companyNew on EvolcNanobiotix
Physics-based nanotherapeutics for cancer, with lead candidate NBTXR3 in clinical development with JanssenNew on EvolcNaobios
GMP contract development and manufacturing of viral vaccines, vectors and other virus-based products for biotech and pharmaceutical sponsorsNew on EvolcRemote-friendly
Website technologies
Older, unverified list. Detection dates and supporting evidence are not yet available.
- Google Ads
- Google Tag Manager
- Google reCAPTCHA
- WordPress